Early detection of treatment response by diffusion-weighted 1H-NMR spectroscopy in a murine tumour in vivo.
about
Diffusion-weighted imaging in musculoskeletal radiology-clinical applications and future directionsMusculoskeletal tumors: how to use anatomic, functional, and metabolic MR techniquesUsing magnetic resonance imaging and spectroscopy in cancer diagnostics and monitoring: preclinical and clinical approachesCharacterizing tumor response to chemotherapy at various length scales using temporal diffusion spectroscopyHigh-field quantitative transverse relaxation time, magnetization transfer and apparent water diffusion in experimental rat brain tumour.Diffusion MRI detects early events in the response of a glioma model to the yeast cytosine deaminase gene therapy strategy.Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imagingShort-term bioeffects of an infrared pulsed laser device on burned rat skin monitored by transverse relaxation times (NMR).Monitoring cytotoxic tumour treatment response by diffusion magnetic resonance imaging and proton spectroscopy.Early response of prostate carcinoma xenografts to docetaxel chemotherapy monitored with diffusion MRI.Photo-induced cytomorphologic changes in an advanced cancer phase I clinical trial.Detecting early response to cyclophosphamide treatment of RIF-1 tumors using selective multiple quantum spectroscopy (SelMQC) and dynamic contrast enhanced imaging.Pretreatment prediction of brain tumors' response to radiation therapy using high b-value diffusion-weighted MRISimultaneous 1H PFG-NMR and confocal microscopy of monolayer cell cultures: effects of apoptosis and necrosis on water diffusion and compartmentalization.Time-Dependent Influence of Cell Membrane Permeability on MR Diffusion Measurements.Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy.Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response.Dynamic contrast-enhanced and diffusion MRI show rapid and dramatic changes in tumor microenvironment in response to inhibition of HIF-1alpha using PX-478.Application of 23Na MRI to monitor chemotherapeutic response in RIF-1 tumors.Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy.The functional diffusion map: an imaging biomarker for the early prediction of cancer treatment outcome.Predicting and monitoring response to chemotherapy by 1,3-bis(2-chloroethyl)-1-nitrosourea in subcutaneously implanted 9L glioma using the apparent diffusion coefficient of water and 23Na MRI.The response of RIF-1 fibrosarcomas to the vascular-disrupting agent ZD6126 assessed by in vivo and ex vivo 1H magnetic resonance spectroscopy.MRI-measured water mobility increases in response to chemotherapy via multiple cell-death mechanisms.A feasibility study evaluating the functional diffusion map as a predictive imaging biomarker for detection of treatment response in a patient with metastatic prostate cancer to the boneTechnology insight: water diffusion MRI--a potential new biomarker of response to cancer therapy.Longitudinal diffusion tensor imaging in a rat brain glioma modelNew insights into tumor microstructure using temporal diffusion spectroscopy.Estimations of intra- and extracellular volume and pH by 31P magnetic resonance spectroscopy: effect of therapy on RIF-1 tumours.Diffusion imaging of human breast.Bone marrow segmentation in leukemia using diffusion and T (2) weighted echo planar magnetic resonance imaging.Uncovering of intracellular water in cultured cells.Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopyThe effect of combretastatin A4 disodium phosphate and 5,6-dimethylxanthenone-4-acetic acid on water diffusion and blood perfusion in tumours.Sensitivity of MR diffusion measurements to variations in intracellular structure: effects of nuclear size.Synergy between anti-CCL2 and docetaxel as determined by DW-MRI in a metastatic bone cancer modelTemporal and dose dependence of T2 and ADC at 9.4 T in a mouse model following single fraction radiation therapy.Positron emission tomography imaging of drug-induced tumor apoptosis with a caspase-3/7 specific [18F]-labeled isatin sulfonamideApplications of the repeatability of quantitative imaging biomarkers: a review of statistical analysis of repeat data setsADC response to radiation therapy correlates with induced changes in radiosensitivity.
P2860
Q26774844-2D447FC2-FE9A-4F8C-B1CE-C4BCA0E75579Q26828595-EB4C4547-585F-476D-8CD7-CC9B1E5497D2Q26865120-D0320355-BC2D-424B-B033-875F5207EE13Q28728870-75D66530-88D4-48C4-B3AE-966FDCB82A71Q30598362-197778F4-6204-4EA7-B1CE-FD1D65A7C100Q30599587-60B4294D-2720-4A33-A814-0531D7D5D0C7Q30606326-28866013-AAB5-40D6-BE1E-8FFFD10E01F2Q30621096-19D03785-0990-40F2-8764-CAD792EA4C37Q30673119-7F8D9542-6B36-4DF2-B4CB-ADD82CC2AED2Q30690776-EA0743D6-A007-4188-A2B1-459C0341B1E8Q30699714-97738472-CD72-4768-9E9F-0CB8C175E5E6Q30790917-7C7E8D11-2904-4EEF-85EF-391C8C0DA2BCQ30930689-5711D618-2F76-4B0E-BBC2-650A6F479D59Q30954817-42696DDF-98BD-4919-A073-D940E5997B07Q30975727-D8440EB9-6547-4597-826D-86B1FE469993Q30983132-94E1CDD9-6A16-485D-8F1A-AA048DE5C06DQ30986317-68A31F30-AC92-4422-8436-AEACB123BC26Q30992467-54F249AA-EB6E-4908-903C-3ACE00D011C1Q30994994-AE758E7F-E91F-4992-BF48-37ED1774C067Q31032006-13AAB71E-F9A8-4B20-AFE1-1745DD281102Q31043513-3ABBA562-58D9-4F3D-8281-B12A6036B68DQ31043569-28082B81-C74D-4445-946F-36CFB9F891E2Q31049713-088523AC-EA9A-43B5-93EE-FFD913EA4626Q31096605-D15F6029-B758-4219-BC9E-C70846958263Q31140219-2BB506B5-7A2E-4070-9BAF-A287CA37F8D3Q31147727-2A51D012-BB11-42DB-88E3-00348E30E8F1Q31155125-E71E93FA-EC13-434D-A412-9DC78CE1BD70Q31162843-729CCF33-72A7-4269-B653-D2C6E970525DQ32019269-954ED802-6CC1-4D1A-A94B-3B2AEF4B4D7AQ32116785-AE22FA3B-53E3-4C0C-B389-CC944998FC67Q33181106-F7E5914B-1598-44EB-97FE-9921D18EA770Q33217539-EDEB3F27-DB83-4B78-A12E-D71D49D01127Q33278673-1B8DDF05-181A-44C9-815A-0D393D08BE84Q33366615-6C535190-B042-4FEC-A09B-C4A835CBA4C0Q33407259-29DF755B-9850-49A2-866D-FA7562A8F26AQ33414714-E753616C-A3BC-4DDA-9CE6-FA139AA2F24AQ33492874-8EE8558D-2760-4462-B5C3-E4A3027EC38AQ33508763-3DCF2BB4-0FD5-45C9-857D-A10E9DB9B1A7Q33517103-0EF1C740-C62B-42CB-B41B-8DCEDCFC9707Q33689750-56B65435-0429-41F9-8050-CA38037D4387
P2860
Early detection of treatment response by diffusion-weighted 1H-NMR spectroscopy in a murine tumour in vivo.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Early detection of treatment r ...... py in a murine tumour in vivo.
@ast
Early detection of treatment r ...... py in a murine tumour in vivo.
@en
type
label
Early detection of treatment r ...... py in a murine tumour in vivo.
@ast
Early detection of treatment r ...... py in a murine tumour in vivo.
@en
prefLabel
Early detection of treatment r ...... py in a murine tumour in vivo.
@ast
Early detection of treatment r ...... py in a murine tumour in vivo.
@en
P2093
P2860
P356
P1476
Early detection of treatment r ...... py in a murine tumour in vivo.
@en
P2093
P2860
P2888
P356
10.1038/BJC.1996.11
P407
P577
1996-01-01T00:00:00Z
P5875
P6179
1056443381